# BioAge Labs, Inc. (BIOA): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for BioAge Labs, Inc. (BIOA) is 3/100, ranked against 24,000+ stocks in 35 markets (Quality 25, Value 34, Momentum 8, each scored against its sector).

- StockRank: 3/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 25, Value 34, Momentum 8: each a 0-100 percentile within Healthcare.
- Position: #25,545 overall, #2,539 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 4.99 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 1.6M.

Source: https://moatmap.ai/stock/BIOA
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker